Checkpoint inhibition • Tumor Mutational Burden • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • TMB (Tumor Mutational Burden) • IDO1 (Indoleamine 2,3-dioxygenase 1)
|
PD-L1 expression
|
Opdivo (nivolumab) • everolimus • Dual TDO/IDO Inhibitor • IDO/TDO dual inhibitor